Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
23/05/2022 07:40
May 23 (Reuters) - HAEMATO AG HAEk.DE :
* Q1 EQUITY RATIO INCREASES FROM 79.5% TO 80.3%
* HAEMATO AG PUBLISHES FIGURES FOR Q1 2022: FURTHER
IMPROVEMENT IN
EBIT MARGIN AND CONFIRMATION OF GUIDANCE
* Q1 EBITDA 2.3 MLN EUR VS 2.8 MLN EUR YR AGO
* Q1 EBIT 2.0 MLN EUR VS 2.4 MLN EUR YR AGO
* Q1 REVENUE 54.6 MLN EUR VS 73.9 MLN EUR YR AGO
Source text for Eikon: ID:nEQ7bJdpka
Further company coverage: HAEk.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln